[{"Assets_0_Q3_USD":727348000.0,"CommonStockSharesOutstanding_0_Q3_shares":60208293.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-132080000.0,"NetIncomeLoss_1_Q3_USD":-64547000.0,"NetIncomeLoss_3_Q3_USD":-170791000.0,"StockholdersEquity_0_Q3_USD":658097000.0,"Ticker":"GBT","CIK":"1629137","name":"GLOBAL BLOOD THERAPEUTICS, INC.","OfficialName":"Global Blood Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2248655788.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]